TearLab Corporation Value Stock - Dividend - Research Selection
Market price: 0,00 USD
TearLab Corporation Fundamental data and company key figures of the share
|Annual reports in USD|
|Net operating cash flow||-954.000|
|Free cash flow||-1.365.000|
|Liabilities & Shareholders equity||14.293.000|
|Diluted shares outstanding||12.309.100|
✓ NEW Fundamental API Access to 500 data points per month
✓ Fundamental data up to 25 years
✓ Comparison to all other stocks by the FScore
✓ Time saving!
How our site works ...
✓ Non-binding 7 days without automatic subscription
✓ No termination required after the free week
✓ Finanzoo fundamental analysis
✓ Data updated daily
✓ Virtual depots
✓ Share alarms via email
✓ Subscription can be canceled at any time at the end of the month
✓ Choice of desired shares
✓ Over 2000 stock analyzes available
✓ Bitcoin payment possible if you do not want to subscribe
Price for monthly subscription $ 19.99 / month including VAT.
|Market Capitalization||738.546,00 USD|
|Raw Data Source|
Description of the company
TearLab Corp. is an in-vitro diagnostic company. The Company is commercializing a tear testing platform, the TearLab Osmolarity System that enables eye care practitioners to test for sensitive and specific biomarkers using nanoliters of tear film at the point-of-care. The Company´s first product measures tear film osmolarity for the diagnosis of Dry Eye Disease (DED). TearLab Research, Inc., its wholly owned subsidiary, develops technologies to enable eye care practitioners to test a range of biomarkers (chemistries, metabolites (i.e. glucose), genes and proteins) at the point-of-care. Commercializing that tear testing platform is the focus of the Company´s business. Its TearLab Osmolarity System, enables the measurement of tear osmolarity in the doctor´s office. The TearLab Osmolarity System consists of three components: the TearLab disposable, the TearLab Pen and the TearLab Reader.